Short answer
MYOMO, INC. (MYO) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Myomo announced financial results for Q3 2026, quarter ended September 30, 2026.
MYOMO, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Myomo announced financial results for Q3 2026, quarter ended September 30, 2026
- Full results and management commentary available in Exhibit 99.1 of the 8-K
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $12.3M, up 22% year over year, driven by 19% unit growth and 2% higher ASP
- Gross margin 71.3% vs 63.8%, while operating expenses rose 6%, producing breakeven Adjusted EBITDA
- Recurring patient sources reached 54% of revenue vs 33%, reducing reliance on less predictable direct patient acquisition
- Cash, equivalents and short-term investments $11.9M, with Q3 operating cash burn $1.3M and debt totaling $13.4M
- Full-year revenue guidance narrowed to $46M-$47M, with second-half cash burn expected below $2M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MYOMO, INC. 8-K filings
Get the next MYO 8-K as it lands
Follow MYO for push alerts, or ask the research agent what this filing means.